Top 10 Fastest-Growing Medical Device Companies of 2025

Recognized by The Financial Times for Outstanding Innovation and Growth

The medical device industry is undergoing a defining transformation — one driven by innovation, data integration, and the pursuit of better patient outcomes. According to The Financial Times, 2025 has marked a breakthrough year for medical technology, with companies reimagining how diseases are monitored, treated, and managed.

From implantable glucose monitors to next-generation robotic surgery systems, the top 10 fastest-growing medical device companies of 2025 are redefining precision, connectivity, and accessibility in healthcare.

A Rapidly Expanding Industry

The pace of medical technology innovation continues to accelerate. Advances in wearable monitoring, robotic-assisted procedures, and AI-driven analytics are enabling faster diagnoses, less invasive treatments, and more personalized care.

At the same time, global healthcare systems are facing unprecedented challenges — from workforce shortages to aging populations and rising rates of chronic disease. These pressures have fueled the demand for remote-capable, user-friendly medical technologies that ease clinical burdens while empowering patients to take control of their health.

According to Fortune Business Insights, the U.S. medical device market alone is projected to exceed $250 billion by 2025, driven by technological advancements and the growing shift toward home-based healthcare.

Against this backdrop, the Financial Times identified a new wave of companies achieving exceptional growth through innovation, agility, and measurable clinical impact. Below, we spotlight the top 10 fastest-growing medical device companies in 2025 — and the breakthroughs propelling their success.

 

1. Procept BioRobotics

Absolute Growth: 1,664.8%

California-based Procept BioRobotics is redefining urologic surgery with its robotic platforms for benign prostatic hyperplasia (BPH). Its flagship Aquablation Therapy — a robotically controlled waterjet treatment — offers durable symptom relief while preserving sexual function.

At the 2025 American Urological Association Meeting, five-year data confirmed lasting clinical benefits, reinforcing Aquablation’s leadership in minimally invasive urology. Procept also launched the HYDROS™ robotic system and expanded its pipeline into new surgical indications, setting new benchmarks for precision and patient safety.

 

2. CVRx

Absolute Growth: 549.2%

Based in Minnesota, CVRx develops implantable neuromodulation systems that address heart failure and hypertension. Its flagship Barostim™ therapy uses electrical impulses to improve cardiovascular performance.

In 2025, real-world data presented at the Technology and Heart Failure Therapeutics (THT) conference showed an 86% reduction in all-cause hospital visits for patients using Barostim, confirming its life-changing potential. Published results in the Journal of Cardiac Failure underscore the growing role of neuromodulation in cardiology.

 

3. RxSight

Absolute Growth: 507.0%

RxSight, headquartered in California, specializes in the world’s only adjustable intraocular lens (IOL) technology. Its Light Adjustable Lens™ enables patients to fine-tune their vision post-surgery using UV light — a breakthrough in personalized cataract care.

In 2024, RxSight achieved 57% revenue growth, driven by a 79% surge in Light Adjustable Lens sales and an expanded global footprint. Its success reflects a growing shift toward smart ophthalmic solutions that combine flexibility, precision, and patient empowerment.

 

4. Inspire Medical Systems

Absolute Growth: 442.0%

Minnesota-based Inspire Medical Systems is transforming sleep medicine through its implantable devices that treat obstructive sleep apnea (OSA) by stimulating airway muscles during sleep — a discreet, effective alternative to CPAP machines.

By 2024, Inspire’s therapy was available in over 1,435 medical centers, with more than 90,000 patients treated worldwide. The company’s upcoming Inspire V system promises even greater efficiency and customization, reinforcing its leadership in digital and implantable sleep health technologies.

 

5. electroCore

Absolute Growth: 359.0%

New Jersey’s electroCore develops non-invasive vagus nerve stimulation (nVNS) therapies for neurological and pain-related disorders. Its Truvaga Plus™ handheld device — honored in the 50 Over 50 Awards — is recognized for promoting stress relief and sleep improvement.

The company’s planned acquisition of NeuroMetrix and its Quell™ neuromodulation platform will expand electroCore’s reach into fibromyalgia and chronic pain management, strengthening its position in the fast-growing non-invasive neuromodulation market.

 

6. Senseonics

Absolute Growth: 352.0%

Headquartered in Maryland, Senseonics continues to lead in long-term continuous glucose monitoring (CGM). Its latest innovation, Eversense® 365, is the world’s first year-long CGM sensor, minimizing the need for frequent replacements and increasing convenience for patients.

In partnership with SweetSpot, Senseonics is expanding into virtual diabetes care, improving data integration and patient engagement. The company grew its global patient base by 56%, with further regulatory submissions planned for the European market.

 

7. Biotricity

Absolute Growth: 256.4%

California-based Biotricity focuses on connected cardiac care. Its partnership with B-Secur launched a device-neutral ambulatory cardiac monitoring platform — enabling healthcare providers to analyze data from multiple devices seamlessly and accurately.

With plans to deliver fully integrated cardiac monitoring solutions, Biotricity is positioning itself at the forefront of continuous digital heart health management.

 

8. Axonics

Absolute Growth: 228.5%

Axonics, headquartered in California, designs advanced neuromodulation systems for bladder and bowel dysfunction. In late 2024, the company’s rapid growth and innovation led to its $3.7 billion acquisition by Boston Scientific, reinforcing Boston Scientific’s leadership in urology and neuromodulation markets.

Axonics’ technologies continue to transform quality of life for patients with overactive bladder and related conditions — a testament to the company’s engineering excellence and clinical impact.

 

9. Haytek Lentes

Absolute Growth: 98.7%

Based in Brazil, Haytek Lentes manufactures premium ophthalmic lenses and vision correction technologies. Its portfolio includes progressive, single-vision, and blue-light protection lenses, all enhanced by advanced coatings for clarity and durability.

Haytek’s ongoing investment in regional manufacturing capacity is expanding access to high-quality optical solutions across Latin America and emerging markets.

10. HCT Solutions

Absolute Growth: 88.0%

U.S.-based HCT Solutions specializes in diagnostic imaging, bioprocessing infrastructure, and life sciences manufacturing systems. Its expertise in controlled environments and process engineering supports the production of vaccines, biologics, and advanced therapies.

Named one of New England’s fastest-growing companies by The Boston Globe, HCT Solutions continues to strengthen the critical supply chain for next-generation biopharma manufacturing.

Shaping the Future of Medical Technology

From robotic-assisted surgeries to year-long glucose sensors, the 2025 Financial Times honorees showcase how rapidly medical device innovation is evolving. Their success reflects more than financial performance — it’s about rethinking care delivery, empowering clinicians, and transforming patient lives.

The future of medicine will be increasingly connected, personalized, and intelligent. These ten companies are proving that when innovation meets compassion, the results are truly life-changing.